Rejuvenate Bio Announces $6 Million Financing and Strategic R&D Collaboration With Merck Animal Health
Hill’s Pet Nutrition Launches Premiere Nutrition Supporting Kidney Function Plus GI and Skin Sensitivities
Elanco Launches Befrena™ (tirnovetmab), New Anti-IL-31 Monoclonal Antibody, a Breakthrough Addition to the $1.3 Billion U.S. Canine Dermatology Market
Hill’s Pet Nutrition and Bond Pet Foods Receive FDA No-Objection Letter for First Animal Protein Produced via Precision Fermentation for Pet Food
Gallant Advances Canine Osteoarthritis IV-Delivered Stem Cell Therapy with Promising Pilot Data and Expanded FDA Conditional Approval Pathway Eligibility
FDA Approves BRAVECTO® QUANTUM (fluralaner for extended-release injectable suspension) from Merck Animal Health to Treat and Control Asian Longhorned Tick and Gulf Coast Tick for 12 Months in Dogs
Elanco Launches Advantage™ Collar for Dogs with Four Months of Continuous Protection from Fleas, Ticks and Mosquitoes*
BiomEdit Initiates Final Field Safety Trial for Non-Antibiotic Poultry Biologic, Advancing Toward USDA Conditional Licensure